ReviewVaccine2024

Safety monitoring of bivalent mRNA COVID-19 vaccine among pregnant persons in the vaccine adverse event reporting System - United States, September 1, 2022 - March 31, 2023.

Pedro L Moro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.